Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework
Br J Surg
.
2022 Dec 13;110(1):10-18.
doi: 10.1093/bjs/znac284.
Authors
Alice E Baggaley
1
,
Guillaume B R C Lafaurie
1
,
Sophia J Tate
2
,
Piers R Boshier
1
,
Amy Case
3
,
Susan Prosser
4
,
Jared Torkington
5
,
Sadie E F Jones
6
,
Sarah H Gwynne
3
,
Christopher J Peters
1
Affiliations
1
Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
2
Department of Anaesthesia, Swansea Bay University Health Board, Swansea, UK.
3
Department of Cancer Services, Swansea Bay University Health Board, Swansea, UK.
4
Department of Library Services, Swansea Bay University Health Board, Swansea, UK.
5
Department of Surgery, University Hospital of Wales, Cardiff, UK.
6
Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK.
PMID:
36056893
PMCID:
PMC10364525
DOI:
10.1093/bjs/znac284
No abstract available
Publication types
Systematic Review
MeSH terms
Aerosols
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Peritoneal Neoplasms* / drug therapy
Peritoneum
Substances
Aerosols
Grants and funding
NIHR